Suppr超能文献

生物精神病学中的催眠、安慰剂与系统性研究偏差。

Hypnosis, placebos, and systematic research bias in biological psychiatry.

作者信息

Hammond D Corydon

机构信息

Physical Medicine & Rehabilitation, University of Utah School of Medicine, 30 No. 1900 East, Salt Lake City, UT 84132-2119, USA.

出版信息

Am J Clin Hypn. 2007 Jul;50(1):37-47. doi: 10.1080/00029157.2007.10401596.

Abstract

In an elaboration on the contribution by Raz (current issue), placebo response is further reviewed in relation to psychotropic drug research. Many therapists are unaware that placebo controlled research documents that antidepressant and anxiolytic drugs on average are only mildly more effective than a placebo. Systematic biases in research design are noted that could account for the small differences. These factors, and turf and financial motivations associated with the rise of "biological psychiatry," are discussed because they impact the practice of clinical hypnosis and psychotherapy. Although placebo research is fascinating and expectancy is certainly an important factor in hypnotic response, thus far, there is little research to support the strong involvement of placebo response as part of hypnotic responsiveness.

摘要

在对拉兹(本期)所做贡献的阐述中,结合精神药物研究对安慰剂反应进行了进一步审视。许多治疗师并未意识到,安慰剂对照研究表明,平均而言,抗抑郁药和抗焦虑药仅比安慰剂略有效。研究设计中存在的系统性偏差被指出,这些偏差可能解释了微小的差异。文中讨论了这些因素,以及与“生物精神病学”兴起相关的地盘之争和经济动机,因为它们影响着临床催眠和心理治疗的实践。尽管安慰剂研究很吸引人,预期肯定是催眠反应中的一个重要因素,但到目前为止,几乎没有研究支持将安慰剂反应作为催眠反应性的重要组成部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验